Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary Infection Based on GenSeizer Platform

NCT04345939 — Unknown, 400 participants, Shanghai Pulmonary Hospital, Shanghai, China

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Rapid and Accurate Detection of Major Mycobacterium Species in Pulmonary

RegistryNCT04345939
StatusUnknown
Study typeObservational
Enrollment400 (Estimated)
SponsorShanghai Pulmonary Hospital, Shanghai, China (Other)
ConditionsMycobacterium Pulmonary Infection
InterventionsDetection method (Diagnostic test)
Datesstart 2021-06-28, primary completion 2024-08-30 (estimated), completion 2024-08-30 (estimated), first posted 2020-04-15, last updated 2021-10-06
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
All trials for Mycobacterium Pulmonary Infection All trials of Detection method

-Summary

Comparison of rapid detection methods of mycobacterial pathogens, GenSeizer v.s. PCR reverse hybridization.

Expand all sections  ·  Collapse all

+Detailed description

The investigators developed a new platform called GenSeizer, which combines bioinformatics analysis of a large dataset with multiplex PCR-based targeted gene sequencing, to identify eleven major Mycobacterium species implicated in human disease. Simultaneous detection of certain antibiotic resistance genotypes, i.e., erm(41) and rrl in M. abscessus, is also feasible. This platform detected both reference strains and clinical isolates with a high degree of specificity and sensitivity.

In this study, the investigators plan to verify the detection efficiency of GenSeizer in clinical samples (sputum, alveolar lavage fluid) and compare it with existing methods on the market (PCR reverse hybridization) and gold standard method (target sequencing after incubation)

+Arms and interventions

ArmTypeInterventionsDescription
GenSeizerDiagnostic Test: Detection methodSputum and lavage fluids are tested for pathogens using GenSeizer
PCR reverse hybridizationDiagnostic Test: Detection methodSputum and lavage fluids are tested for pathogens using PCR reverse hybridization
Target sequencing after incubationDiagnostic Test: Detection methodSputum and lavage fluids are tested for pathogens using Target sequencing after incubation
  • Detection method (Diagnostic test): Different methods for pathogen diagnosis

+Outcome measures

Primary outcomes

  • Detection accuracy [through study completion, an average of 3 years]

+Eligibility

Sex: All, ages: 16 Years to 70 Years

Inclusion Criteria:

* Suspected cases of mycobacterial lung infection

Exclusion Criteria:

* No sputum
* Refused or unable to tolerate bronchoscopy

+Locations (1)

FacilityCityCountryStatus
Haiqing ChuShanghaiChinaRecruiting